Skip to main content
. 2023 Jun 13;11(6):1699. doi: 10.3390/biomedicines11061699

Figure 1.

Figure 1

Major peripheral blood mononuclear cells (PBMCs) populations in MPS II, MPS VI disease patients, and control subjects. (A) Gating strategy used to identify T cells (CD3+); B cells (CD19+); NK cells (CD56+ CD3) and monocytes (CD14+) populations. (B) Percentage of T cells, B cells and NK cells was determined among lymphocytes and of monocytes among PBMCs. Horizontal bars represent mean values. * p < 0.05.